Aviation securityBioStorage approved for cargo pre-screens
Shipments of pharmaceutical and biotech materials typically include temperature- and time-sensitive materials — but under the Implementing Recommendations of the 9/11 Commission Act, which took effect 1 August, all cargo transported on passenger aircraft is required to be screened at the piece level, prior to being transported; TSA approves Indiana-based BioStorage Technologies to pre-screen its shipments to avoid airport delays
The U.S. Transportation Security Administration (TSA) has approved Indiana’s BioStorage Technologies to pre-screen its shipments to avoid airport delays.
Shipments of pharmaceutical and biotech materials by BioStorage typically include temperature- and time-sensitive materials. Under the Implementing Recommendations of the 9/11 Commission Act, which took effect 1 August, all cargo transported on passenger aircraft is required to be screened at the piece level, prior to being transported.
UPI reports that by doing its own clearance, the company could reduce inspection delays at an inspection terminal and also the risk of transportation damage to the shipped materials, BioStorage said.
“This new mandate highlights how complex and intricate the pharmaceutical and biotech supply chain has become, which has been exacerbated by time and temperature constraints placed on many biomaterials and medical products,” says Lori A. Ball, chief operating officer, BioStorage Technologies. “Qualifying as a certified cargo screening facility reinforces our commitment to being a leader in sample management while allowing us to provide our customers with prompt and cost-effective shipping of temperature-sensitive biological samples.”
